Advertisement
Research Article Free access | 10.1172/JCI42680
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Wada, T. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Ishiwata, K. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Koseki, H. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Ishikura, T. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Ugajin, T. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Ohnuma, N. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Obata, K. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Ishikawa, R. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Yoshikawa, S. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Mukai, K. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Kawano, Y. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Minegishi, Y. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Yokozeki, H. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Watanabe, N. in: JCI | PubMed | Google Scholar
1Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. 2Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. 3Laboratory for Developmental Genetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan. 4Department of Dermatology and 5Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Find articles by Karasuyama, H. in: JCI | PubMed | Google Scholar
Published July 26, 2010 - More info
Basophils are the least abundant granulocytes found in the circulation. Until recently, their functions were poorly understood. In the past few years, the list of basophil functions in the context of immunity has dramatically increased. Thus, the need for basophil-deficient animal models to confirm these findings is imperative. In this issue of the JCI, Wada and colleagues introduce the first mouse model in which basophils are conditionally ablated in vivo. Using this model, they then uncover a nonredundant role for basophils in acquired immunity against tick infection.
Booki Min
Ticks are ectoparasitic arthropods that can transmit a variety of microorganisms to humans and animals during blood feeding, causing serious infectious disorders, including Lyme disease. Acaricides are pharmacologic agents that kill ticks. The emergence of acaricide-resistant ticks calls for alternative control strategies for ticks and tick-borne diseases. Many animals develop resistance to ticks after repeated infestations, but the nature of this acquired anti-tick immunity remains poorly understood. Here we investigated the cellular and molecular mechanisms underlying acquired resistance to Haemaphysalis longicornis ticks in mice and found that antibodies were required, as was IgFc receptor expression on basophils but not on mast cells. The infiltration of basophils at tick-feeding sites occurred during the second, but not the first, tick infestation. To assess the requirement for basophil infiltration to acquired tick resistance, mice expressing the human diphtheria toxin receptor under the control of the mast cell protease 8 (Mcpt8) promoter were generated. Diphtheria toxin administration to these mice selectively ablated basophils. Diphtheria toxin–mediated basophil depletion before the second tick infestation resulted in loss of acquired tick resistance. These data provide the first clear evidence, to our knowledge, that basophils play an essential and nonredundant role in antibody-mediated acquired immunity against ticks, which may suggest new strategies for controlling tick-borne diseases.
Ticks, particularly members of the Ixodid family, are blood-feeding ectoparasites of vertebrates and are also important vectors of pathogens, including virus, bacteria, protozoa, and helminths, which can cause several serious infectious diseases in humans and animals (1, 2). Ticks suck a blood meal from hosts over a period of several days and increase their body weight up to 120-fold. Once they replete with blood meal (engorgement), ticks drop off from the host. While feeding, various substances of ticks are injected into the host to facilitate successful blood feeding, including a cement to anchor the mouth parts to the skin of the host, enzymes, vasodilators, and antiinflammatory, antihemostatic, and immunosuppressive substances (3–5). Pathogens can be transmitted from infected ticks to the host during salivation. Tick-transmitted diseases include viral encephalitis, Lyme disease caused by spirochetes of the Borrelia burgdorferi, Rocky Mountain spotted fever caused by Rickettsia rickettsii, monocytic human ehrlichiosis caused by Ehrlichia chaffeensis, and babesiosis caused by protozoa Babesia (1). The public health importance of ticks is not diminishing, and the emergence of acaricide-resistant ticks has shifted the anti-tick strategy toward the immunological control of ticks (6–8).
Several species of animals, including guinea pigs, rabbits, bovines, and mice, have been shown to develop resistance to tick feeding after a single or multiple infestation with ticks (6), which is characterized by reduced numbers and weights of engorged ticks or tick death in subsequent infestations. Acquired host resistance to tick infestation was first documented by Trager in 1938 (9) and extensively studied by using guinea pigs in the 1970s and 1980s. It can be transferred to naive animals with cells or sera isolated from infested animals, and therefore the resistance is considered to be a type of immunological reaction (9–11). Immune resistance to the ticks is an important element of protection from infestation with these ectoparasites and also contributes significantly to the reduction in pathogen transmission from infected ticks (12–15). This is the rationale for the development of tick antigen–based vaccines to prevent tick-borne diseases. However, the nature of naturally acquired protective immunity against ticks remains ill defined. The tick-feeding sites in guinea pigs that had already experienced tick infestation were characterized by large accumulation of basophils and eosinophils, and basophils compose up to 70% of the infiltrating cells (10, 11, 16). One study reported that the treatment of such guinea pigs with basophil-depleting antiserum abolished tick resistance, suggesting the importance of basophils for acquired tick resistance (17). However, it remains elusive whether this important finding can be generalized to other animal species including humans. In particular, mice were erroneously believed for a long time to lack basophils, due to the difficulty in identifying them (18–20), and no role in acquired tick resistance in mice has been shown for basophils. Instead, one research group suggests that mast cells in place of basophils are important for acquired immunity to ticks in mice, based on the observation that mast cell–deficient mice failed to acquire tick resistance and that basophils were not detected in tick-feeding sites (21–23). On the other hand, another group showed that the same strain of mast cell–deficient mice developed resistance to another tick species (24, 25). Thus, the mechanism underlying acquired immunity to ticks, including the differential roles played by basophils and mast cells, and the influence of genetic background of both ticks and hosts remain to be clarified.
Studies on basophils, particularly their functions in vivo, have long been hampered by the lack of suitable animal models, including mice that are deficient only in basophils. We have recently established a CD200R3-specific mAb Ba103 (26, 27) that can deplete most basophils when administered into mice. MAR-1, a mAb specific to FcεRIα, also shows a similar basophil-depleting ability (28, 29). The use of these mAbs successfully identified previously unrecognized roles for basophils in allergic reactions and the regulation of acquired immunity (30–33), including IgE-mediated chronic cutaneous allergic inflammation (26, 34), IgG-mediated systemic anaphylaxis (35), and promotion of humoral memory responses (29) and Th2 cell differentiation (28, 36–38). Thus, the mAbs are very useful for analyses of in vivo functions of basophils. However, they might not be perfect in some experimental settings, especially those in which mast cells substantially contribute to a reaction of interest, since the mAbs react to both mast cells and basophils (26, 27, 29). Possible side effects of the treatment with the mAbs have to be considered, including activation, unresponsiveness after activation, or partial depletion of mast cells (29). This may make the interpretation of obtained data complicated, whether the phenotype of antibody-treated mice is due to either the basophil depletion or some deleterious effects on mast cells or both.
In the present study, to overcome the limitation of antibody-mediated basophil depletion, we utilized the technology of diphtheria toxin–mediated (DT-mediated) cell ablation (39) and generated engineered mice that allow selective ablation of basophils by means of basophil-specific expression of receptors for DT. Taking advantage of this mouse model, we examined the possible involvement of basophils in acquired tick resistance to Haemaphysalis longicornis in mice, for which mast cells are reportedly essential (21–23). H. longicornis is an important vector for human and animal pathogens, including those causing babesiosis, Q fever, and Russian encephalitis (40). We found that basophils but not mast cells directly contribute to the antibody/IgFc receptor–mediated manifestation of tick resistance, even though both types of cells are required for tick resistance.
IgFc receptors on mast cells are dispensable for antibody-mediated, protective immunity against ticks. Acquired tick resistance is characterized by reduced numbers and weights of engorged ticks in the second infestation compared with the first. Therefore, to evaluate tick resistance, we used “relative tick repletion” (defined in Methods) as a quantitative measure of tick feeding that takes into account both the number and body weight of engorged ticks. The stronger the tick resistance, the lower the relative tick repletion in the second infestation. When C57BL/6 mice were infested with larval H. longicornis ticks twice at an interval of 14 days, the tick repletion in the second infestation typically decreased to approximately 60%–70% of that in the first one (Figure 1A and Supplemental Table 1; supplemental material available online with this article; doi: 10.1172/JCI42680DS1). In contrast, mast cell–deficient C57BL/6-KitW-sh/W-sh mice showed approximately 100% tick repletion in the second infestation as in the first one (Figure 1B). Adoptive transfer of bone marrow–derived mast cells (BMMCs) from wild-type C57BL/6 mice into the skin of C57BL/6-KitW-sh/W-sh mice resulted in approximately 60% tick repletion in the second infestation (Figure 1C), as observed in wild-type C57BL/6 mice (Figure 1A). These results demonstrated that C57BL/6 mice acquire the resistance to tick feeding once they have experienced the tick infestation and that mast cells play an important role in the acquisition of tick resistance, consistent with previous reports using other strains of mast cell–sufficient and –deficient mice, WBB6F1+/+ and WBB6F1-KitW/W-v, respectively (21, 22).
IgFc receptors on mast cells are dispensable for antibody-mediated, protective immunity against ticks. (A) C57BL/6 and (B) C57BL/6-KitW-sh/W-sh mice were infested with larval H. longicornis ticks once or twice at an interval of 14 days. The relative tick repletion in each experimental group is shown, in that the value in the first infestation was defined as 100%. Data are shown as mean ± SEM, n = 5 (A); n = 4 (B). (C) BMMCs derived from wild-type mice were adoptively transferred to KitW-sh/W-sh mice, and the recipient mice were infested and analyzed as in A. Data are shown as mean ± SEM, n = 3 each. (D) μMT and (E) Fcer1g–/– C57BL/6 mice were infested with ticks as in A, and the relative tick repletion in each group is shown. Data are shown as mean ± SEM, n = 5 (D); n = 4 (E). (F) BMMCs derived from Fcer1g–/– mice were adoptively transferred to KitW-sh/W-sh mice, and the recipient mice were infested and analyzed as in A. Data are shown as mean ± SEM, n = 3 each. Data shown in A–F are representative of at least 3 repeated experiments. **P < 0.01.
Previous studies showed that transfer of serum from tick-infested but not uninfested mice conferred tick resistance on naive mice and that heat inactivation of the serum at 56°C for 2 hours abolished this activity, suggesting that antibodies made against ticks, particularly of the IgE class, are involved in the manifestation of tick resistance (23). In accordance with this, neither antibody-deficient μMT mice nor Fcer1g–/– mice, which lack the expression of IgE receptor (FcεRI) and stimulatory IgG receptors, displayed acquired tick resistance in the second infestation (Figure 1, D and E). Unexpectedly, however, mast cell–deficient KitW-sh/W-sh mice reconstituted with BMMCs derived from Fcer1g–/– mice did develop tick resistance (Figure 1F), as did mice reconstituted with wild-type BMMCs (Figure 1C). This finding demonstrated that Ig receptors on mast cells are dispensable for the antibody-mediated acquired tick resistance and suggested a previously unrecognized mechanism for acquisition of tick resistance, distinct from the proposed scenario that tick antigens stimulate skin-resident mast cells through their binding to IgE/FcεRI on the cell surface, leading to an immediate-type hypersensitivity reaction against ticks (23). Given that the surface expression of FcεRI is restricted to mast cells and basophils in mice, basophils might be involved in antibody-mediated acquired tick resistance.
Recruitment of basophils to tick-feeding sites during the second, but rarely the first, infestation. Giemsa staining of skin tissue sections failed to detect basophils infiltrating the tick-feeding sites (data not shown), consistent with previous reports (21, 25, 41). Nevertheless, we readily detected Mcpt8 transcripts, which encode the basophil-specific, granzyme B–like protease mMCP-8 (42–44) in tick-feeding–induced skin lesions 18 and 48 hours after the initiation of a second infestation; almost none were detected during the first infestation (Figure 2A). Flow-cytometric analysis of cells isolated from the tick-feeding sites revealed the presence of infiltrating basophils as early as 12 hours after the initiation of the second infestation, but such basophils were rare during the first one (Figure 2B). The number of basophils at the skin lesions increased approximately 40 times from the beginning to the 96-hour time point of the second infestation (Figure 2B). Finally, an immunohistochemical examination using a recently established anti-mMCP-8 mAb (TUG8) (44) demonstrated that mMCP-8–expressing basophils were recruited to and clustered around the tick mouth parts during the second, but rarely the first, infestation (Figure 2C). Other types of cells, including eosinophils and neutrophils, also increased their number in the tick-feeding sites during the second infestation compared with the first one (Supplemental Figure 1).
Recruitment of basophils to tick-feeding sites during the second, but rarely the first, infestation. (A) C57BL/6 mice were infested with ticks as in Figure 1. Tick-feeding–site skin lesions were isolated at the indicated time points during the first and second infestations and subjected to semiquantitative RT-PCR analysis (PCR templates were 5-fold serially diluted) for the expression of basophil-specific Mcpt8, mast cell–specific Mcpt4, and housekeeping Hprt1 transcripts. (B) Skin lesions caused by tick feeding were isolated at the indicated time points during the first (black circles) and second (white circles) infestations and subjected to flow cytometric analysis. Changes in the number of basophils during the infestations are shown. Data are shown as mean ± SEM, n = 3 each. (C) Tick-feeding–site skin lesions were isolated 18 hours after the initiation of the first or second infestation and subjected to immunohistochemical examination using anti–mMCP-8 or an isotype-matched control antibody. mMCP-8–expressing basophils were stained in brown. Scale bars: 100 μm. Data shown in A–C are representative of at least 3 repeated experiments.
Treatment of mice with basophil-depleting antibodies abolishes acquired tick resistance. We next examined the possible role for basophils infiltrating the tick-feeding sites. The treatment of mice with the basophil-depleting anti-CD200R3 mAb Ba103 (26, 27) before the second infestation (Supplemental Figure 2) resulted in a drastically reduced number of infiltrating basophils (Figure 3A) and approximately 100% tick repletion in the second infestation (Figure 3B), while approximately 60% tick repletion (the same as in untreated mice) was seen when a control antibody was used (Figure 3B). Similar results were obtained when another basophil-depleting mAb, MAR-1, specific to FcεR1α (28, 29), was used instead of Ba103 (Figure 3C and Supplemental Figure 2). When used to treat mice prior to the first infestation, neither Ba103 nor MAR-1 had a significant effect on the tick repletion in the first infestation (Figure 3D and data not shown). These results supported the idea that basophils critically contribute to protection against ticks during the second infestation. However, the interpretation of these data was not so simple as compared with that in mast cell–independent reactions such as IgE-mediated chronic cutaneous allergic inflammation (26, 34), since both Ba103 and MAR-1 react with mast cells as well as basophils (26, 27, 29). Mast cell–deficient mice failed to acquire tick resistance (Figure 1B), and therefore we could not formally exclude the possibility that the treatment of mice with Ba103 or MAR-1 had a deleterious effect on mast cell functions that led to the loss of tick resistance.
Treatment of mice with basophil-depleting antibodies abolishes acquired tick resistance. (A–C) C57BL/6 mice were infested once or twice and treated with Ba103 (A and B), MAR-1 (C), or an isotype-matched control (Cont) antibody or left untreated (none) before the second infestation. A shows the number of basophils infiltrating the tick-feeding site 2 days after the initiation of the second infestation. Data are shown as mean ± SEM, n = 3 each. The relative tick repletion in each experimental group is shown in B and C, in that the value in the first infestation was defined as 100%. Data are shown as mean ± SEM, n = 5 (B); n = 4 (C). (D) C57BL/6 mice were infested once with ticks after the treatment of Ba103 or control antibody or without any treatment (none). Data are shown as mean ± SEM, n = 4 each. Data shown in A–D are representative of at least 3 repeated experiments. **P < 0.01; *P < 0.05.
Generation of Mcpt8DTR mice for selective and inducible ablation of basophils. To overcome the limitation of antibody-mediated basophil depletion in discrimination of in vivo functions between basophils and mast cells, we generated Mcpt8DTR mice that express the human DT receptor (DTR) only in basophils, which makes it possible to specifically and inducibly deplete basophils by treatment with DT. These mice harbor a cDNA-encoding DTR fused to GFP and an internal ribosome entry site (IRES) inserted into the 3′ untranslated region of the basophil-specific Mcpt8 gene (Figure 4A). As expected, GFP was expressed only in the basophils of Mcpt8DTR mice and not in other cell types, including mast cells, neutrophils, or eosinophils (Figure 4B). DT injection into the Mcpt8DTR mice led to the transient depletion of basophils from the bone marrow, peripheral blood, and spleen (Figure 4, C and D, and Supplemental Figure 3) but did not affect other cell types, including peritoneal and dermal mast cells (Figure 4, C and E, and Supplemental Figure 3). IgE-mediated, passive cutaneous anaphylaxis was elicited normally in the DT-treated Mcpt8DTR mice (Figure 4F), demonstrating that the function of the mast cells was also intact. However, tick resistance was abolished when the Mcpt8DTR mice were treated with DT but not vehicle (PBS) before the second infestation (Figure 5A), concomitant with the depletion of basophils, but not mast cells, from the tick-feeding sites (Figure 5, B and C). The DT treatment showed no significant effect on the number of basophils or tick resistance in control littermates (Supplemental Figure 4), and the adoptive transfer of basophils from control littermates reconstituted tick resistance in the DT-treated Mcpt8DTR mice (Supplemental Figure 5). These findings clearly demonstrated the importance of basophils in the manifestation of tick resistance.
Generation of Mcpt8DTR mice for selective and inducible ablation of basophils. (A) Schematic diagram of Mcpt8DTR targeting construct. Exons are shown as black boxes. The restriction sites indicated are as follows: E, EcoRV; S, SalI; A, AflII. A SalI site engineered in the 3' untranslated region of the Mcpt8 gene was used to clone the IRES-DTR-EGFP-loxP-Neo-loxP cassettes. Neo cassette was removed by Cre-mediated recombination after mating with CAG-cre deleter mice. (B) Flow cytometric analysis of GFP expression in immune cells from Mcpt8DTR (white histogram) or wild-type littermate (shaded histogram) mice. Data are shown for basophils, neutrophils, and eosinophils in the bone marrow; mast cells in the peritoneal cavity; and T cells, B cells, NK cells, macrophages, plasmacytoid DCs (pDCs), and conventional DCs (cDCs) in the spleen. (C–F) Mcpt8DTR mice were treated with DT (750 ng/20 g body weight) or vehicle (PBS). The percentage of basophils (as indicated by the numbers in the panels) in the bone marrow and mast cells in the peritoneum 3 days after the injection are shown in C. The change in percentage of basophils in the peripheral blood after the injection is plotted in D. The number of mast cells in the flank skin 3 days after the injection is shown in E. Data are shown as mean ± SEM, n = 3 each. (F) Mice were subjected to passive cutaneous anaphylaxis 3 days after the DT injection. Data are shown as mean ± SEM, n = 4 each. Data shown in B–F are representative of at least 3 repeated experiments. *P < 0.05.
DT-mediated basophil ablation in Mcpt8DTR mice abolishes acquired tick resistance. Mcpt8DTR mice were infested once or twice with ticks as in Figure 1. DT or vehicle (PBS) was administered twice, 2 days before and 2 days after the initiation of the second infestation. The relative tick repletion for each group is shown in A. Data are shown as mean ± SEM, n = 3 each. (B and C) Numbers of basophils and mast cells in the tick-feeding sites 4 days after the initiation of the second infestation. Data are shown as mean ± SEM, n = 3 each. Data shown in A–C are representative of at least 3 experiments. **P < 0.01; *P < 0.05.
IgFc receptors on basophils are essential for antibody-mediated, protective immunity against ticks. We next examined the possible contribution of basophils to the antibody dependency of acquired tick resistance. The adoptive transfer of basophil-enriched CD49b+ spleen cells from wild-type mice that had been infested with ticks once, but not of those from uninfested mice, conferred tick resistance on naive mice (Figure 6A). This was also the case when basophil-enriched CD49b+ spleen cells from infested Mcpt8DTR mice were used as the donor cells, and DT-mediated basophil depletion of the donor mice before the transfer abolished the acquisition of tick resistance in the recipients (Figure 6B). These results strongly suggested that anti-tick antibody–armed basophils played a critical role in antibody-mediated tick resistance. Indeed, the adoptive transfer of wild-type, but not Fcer1g–/– basophil–enriched, spleen cells from infested mice conferred tick resistance on naive mice (Figure 6C). Taken together with the result shown in Figure 1F, the expression of Ig receptors on basophils but not mast cells is required for the manifestation of tick resistance.
IgFc receptors on basophils are essential for antibody-mediated, protective immunity against ticks. (A) The CD49b+ basophil–enriched fraction of splenocytes from C57BL/6 mice infested only once (sensitized) or never (naive) was adoptively transferred into naive, uninfested C57BL/6 mice, and 2 hours later, the recipient mice were infested with ticks. The relative tick repletion for each group is shown. The value for the control, vehicle-treated mice was defined as 100%. Data are shown as mean ± SEM, n = 3 each. (B) The basophil-enriched fraction of splenocytes from DT- or PBS-treated Mcpt8DTR mice that had been infested once was adoptively transferred into naive, uninfested littermate control mice. The recipient mice were then infested, and the relative tick repletion is shown as in A. Data are shown as mean ± SEM, n = 3 each. (C) The basophil-enriched fraction of splenocytes from wild-type or Fcer1g–/– mice that had been infested once was adoptively transferred into naive, uninfested C57BL/6 mice, which were then infested. The relative tick repletion is shown as in A. Data are shown as mean ± SEM, n = 3 each. Data shown in A–C are representative of at least 3 repeated experiments. **P < 0.01.
Basophils account for less than 1% of peripheral blood leukocytes and share several characteristics with tissue-resident mast cells, including the surface expression of FcεRI. Therefore, basophils have long been considered to have minor, redundant roles in immune responses (45). Recent studies have illuminated previously unrecognized roles for basophils in both allergic responses and immune regulation (30–33). However, our understanding of the role of basophils in protective immunity to pathogens is still very limited compared with that of mast cells (46, 47). In the present study, we created a mouse strain suitable for analysis of basophil functions in vivo and uncovered the critical role for basophils in acquired resistance against blood-feeding tick H. longicornis in mice. Importantly, basophils but not mast cells are responsible for the antibody/IgFc-mediated acquisition of tick resistance, even though both types of cells are essential for the manifestation of resistance.
Mcpt8DTR, a mouse model for selective and inducible ablation of basophils established in the present study, is exactly what many researchers studying basophils and mast cells have long been eager for (30–33). The discovery of mast cell–deficient mice, including KitW/W-v and KitW-sh/W-sh mice, has greatly advanced our understanding of mast cell functions in vivo (48). In contrast, neither natural nor genetically engineered mutant mice deficient only in basophils were available, which was a great obstacle in the basophil research. The establishment of Mcpt8DTR mice has clearly solved the problem associated with antibody-mediated basophil depletion using Ba103 or MAR-1, which reacts to mast cells as well as basophils (26, 27, 29), and hence has potential to produce unwanted side effects on mast cells. The expression of DTR in Mcpt8DTR mice is under the control of the Mcpt8 promoter and regulatory elements, and the DT treatment depletes only basophils and leaves mast cells intact. Inducible depletion of basophils could also minimize possible compensation of basophil functions by other types of cells, compared with mice that are permanently deficient for basophils. Taking advantage of the selective and inducible ablation of basophils in Mcpt8DTR mice, we definitely demonstrated that basophils play an essential role in the acquired protective immunity to H. longicornis in mice in contrast to the previously proposed scenario that mast cells substitute for basophils in the acquisition of tick resistance in mice, unlike in guinea pigs (23).
Previous studies showed that the number of mast cells increased at tick-feeding sites in mice with acquired tick resistance, whereas no infiltrating basophils were detected (21, 25, 41). In the present study, by using the recently established anti–mMCP-8 mAb TUG8, which is suitable for immunohistochemical staining of basophils in tissue sections (44), we clearly identified infiltrating basophils that made clusters surrounding tick mouth parts at H. longicornis feeding sites during the second but not first infestation. Thus, the absence of infiltrating basophils at the tick-feeding sites as reported in the previous studies (21, 25, 41) is probably due to the difficulty in identifying mouse basophils by conventional methods such as Giemsa staining (19, 20). We further demonstrated that the selective depletion of basophils abolished the acquired tick resistance. On the other hand, we confirmed the previous observation that the absence of mast cells resulted in the loss of acquired tick resistance (21–23). Thus, both basophils and mast cells critically contribute to the manifestation of tick resistance. However, their contribution does not seem additive, since the absence of either basophils or mast cells led to the complete loss of acquired tick resistance, and the antibody-mediated depletion of basophils in mast cell–deficient mice showed no significant effect on tick repletion in the second infestation (data not shown). These results suggested that basophils and mast cells might have distinct roles in the acquisition of tick resistance. Indeed, the expression of IgFc receptors on basophils but not mast cells was required for it, indicating that the antibody-mediated acquisition of anti-tick immunity is ascribed to basophils rather than mast cells.
It remains to be determined how basophils and mast cells accomplish tick resistance in a cooperative or independent manner. Basophil infiltration in the tick-feeding sites was normally observed even in KitW-sh/W-sh or μMT mice (Supplemental Figure 6, A and B), demonstrating that neither mast cells nor antibodies are essential for the recruitment of basophils, although both are required for the manifestation of acquired tick resistance. Moreover, the recruitment of eosinophils and neutrophils was also detected normally in mast cell–deficient or basophil-depleted mice (Supplemental Figures 6C and 7), while tick resistance was lost in these mice, suggesting that their recruitment is independent of basophils and mast cells and may be insufficient or dispensable for the manifestation of tick resistance. There are at least 2 possibilities in the interplay of basophils and mast cells: mast cells may help the priming, activation, or effector function of basophils in tick rejection. Alternatively, antigen/antibody-stimulated basophils may function as activators of mast cells that in turn produce effector molecules against ticks. A previous study using mice infested with another tick species, Dermacentor variabilis, demonstrated that mast cells were not essential for acquired tick resistance (24). To our knowledge, the contribution of mast cells to tick resistance has not been reported in other animal species, including guinea pigs. Thus, the extent of contribution of mast cells to acquired tick resistance may depend on the combination of host animal and tick species. Given that basophils cluster closer to tick mouth parts than mast cells, we assume that basophils rather than mast cells function as direct effectors of the anti-tick reaction mounted in response to tick antigens in our mouse model. The effector molecules involved in the manifestation of tick resistance remain to be identified. Immunohistochemical staining for mMCP-8 indicated that the basophils that were adjacent to tick mouth parts had degranulated to release mMCP-8 (Figure 2C), which is a basophil-specific, granzyme B–like serine protease that is stored in the secretory granules of basophils (42–44). We recently reported that a tryptase, mMCP-11, is also preferentially expressed by basophils and stored in their secretory granules (44). The mast cell protease mMCP-6 has been shown to play an immunoprotective role in bacterial and helminth infections (49, 50). Therefore, the basophil-derived mMCP-8 and mMCP-11, among other factors, may contribute to tick resistance. Further studies, including the generation of mice deficient for these proteases, are needed to explore this possibility.
Recent studies demonstrated that basophils can enter lymph nodes, initiate Th2 responses, and enhance humoral memory responses in certain experimental settings (28, 29, 36–38). The infestation of mice with H. longicornis greatly increases serum IgE levels (23), suggesting that the tick infestation induces Th2-type immune responses. We detected the recruitment of basophils expressing MHC class II and CD86 to regional lymph nodes during the first infestation with ticks (Supplemental Figure 8A). However, the DT-mediated basophil depletion in the first infestation did not show any significant effect on increased levels of serum IgE (Supplemental Figure 8B) or the manifestation of acquired tick resistance in the second infestation (Supplemental Figure 9), although it abolished the basophil recruitment to the lymph nodes (Supplemental Figure 8A). The basophil depletion in the second infestation also showed no significant impact on serum IgE levels (Supplemental Figure 8B), even though it abolished acquired tick resistance (Figure 5A). These results imply that the loss of acquired tick resistance in the basophil-depleted mice may not be due to the failure in Th2-induced IgE production. Moreover, as shown in Figure 6, the adoptive transfer of basophils from infested mice conferred tick resistance on naive mice in that T cells and B cells had not been primed with tick antigens. This suggests that the enhancement of T and B cell memory responses mediated by basophils, if any, may not be essential for the manifestation of acquired tick resistance, even though our observations do not exclude roles for basophils in the promotion of Th2 response and the enhancement of memory response during tick infestation.
The present study reconciles the apparent discrepancy between guinea pigs and mice in the cellular components each requires for acquired tick resistance (17, 21–25) and illuminates a nonredundant role for basophils in protective immunity to ectoparasites. The acquisition of tick resistance is associated with reduced pathogen transmission from infected ticks (12–15), and therefore our findings may provide new avenues toward the development of novel control strategies for tick infestations and tick-borne diseases. Finally, since the study of basophils has long been hampered by the lack of basophil-deficient animal models, the establishment of Mcpt8DTR mice in the present study should facilitate our understanding of the in vivo roles played by basophils under physiological and pathological conditions.
Mice. C57BL/6 mice were purchased from Japan SLC. Fcer1g–/–, μMT, and KitW-sh/W-sh C57BL/6 mice were described previously (51–53). KitW-sh/W-sh C57BL/6 mice were provided by S.J. Galli (Stanford University, Stanford, California, USA), S. Nakae (University of Tokyo, Tokyo, Japan), and K. Sudo (Tokyo Medical University, Tokyo, Japan). CAG-cre transgenic mice were provided by J. Miyazaki (Osaka University, Osaka, Japan). Mice were maintained under specific pathogen–free conditions in our animal facilities. All animal studies were approved by the Animal Research Committee of Tokyo Medical and Dental University and the Animal Care Committee of the Jikei University School of Medicine.
Generation of Mcpt8DTR mice. The targeting construct used to generate the Mcpt8DTR mice was made by subcloning a 10-kbp EcoRV fragment of Mcpt8 containing exons 1–5 from a C57BL/6 mouse genomic DNA BAC library (BPRC) into the pBluescript II (Stratagene) vector. During this step, the SalI site was destroyed, and a pMC1-DTA negative-selection cassette was then inserted into the SmaI site. A SalI restriction site was engineered into the 3′ untranslated region of Mcpt8, upstream of the polyadenylation signal. The PCR-amplified IRES-huDTR cDNA as an EcoRI/BamHI fragment was cloned into pEGFP-N3 (Stratagene) to generate the gene encoding the IRES-huDTR-EGFP fusion protein, which was then cloned into the MCS-BGHpA-loxP-Neo-loxP shuttle vector. The IRES-huDTR-EGFP-BGHpA-loxP-Neo-loxP fragment was cloned into the above-mentioned SalI site. The linearized targeting vector was electroporated into embryonic stem cells. G418-resistant clones were screened for homologous recombination by Southern blotting analysis. Clones carrying the correctly targeted locus were injected into BDF2 blastocysts to generate chimeric mice. These chimeras were subsequently crossed with C57BL/6 females. Chimeric offspring were mated to CAG-cre transgenic mice (54) to excise the PGK-Neo cassette. Mice were backcrossed to C57BL/6 at least 6 times before use.
Ticks and tick infestation. H. longicornis of the Okayama strain was provided by K. Fujisaki (Kagoshima University, Kagoshima, Japan). H. longicornis larvae were used at 4–10 weeks of age for the cutaneous infestation of mice as described (21). A patch of the mouse’s flank was shaved, and a short piece of acrylic pipe with 40 larvae in it was attached to the skin. The open end of the pipe was covered with nylon gauze to prevent the ticks from escaping. Of the 40 larvae applied initially, those that detached over a period lasting up to 8 days were defined as being engorged. Under our experimental conditions, approximately 85% of the ticks became engorged during the first infestation, regardless of the mouse strain examined, and the rest of them failed to feed and died. The mean body weight of the engorged ticks in the first infestation was typically approximately 750 μg, regardless of the mouse strain, whereas that of unengorged ticks was only approximately 1–2 μg. To assess the acquisition of tick resistance, mice were infested with tick larvae at 2 different locations. The initial infestation was on the left flank. Two weeks later, the second infestation was started on the right flank. In mice that had become resistant to ticks, both the number and body weight of the engorged ticks was reduced compared with naive mice (Supplemental Table 1). For evaluation of tick resistance, we summed up the body weight of all engorged ticks in each mouse as our measure of tick feeding and calculated “relative tick repletion.” Relative tick repletion (%) = 100 × the sum of the body weights of all engorged ticks in the test experiment/the sum of the body weights of all engorged ticks in the reference experiment. When the tick repletion in the first infestation was defined as 100%, that in the second infestation was typically approximately 60%–70% in C57BL/6 mice. Because the body weight of unengorged ticks is negligible compared with that of engorged ones, the relative tick repletion in the second infestation compared with the first one actually represents the ratio of the total weight of all ticks in the second infestation to that in the first infestation.
Antibodies. PE-conjugated mAbs specific to Siglec-F (E50-2440), c-kit (2B8), NK1.1 (PK136), CD11b (M1/70), CD19 (1D3), and B220 (RA3-6B2) and biotinylated mAbs specific to mouse IgE (R35-72), CD49b (DX5), CD11c (HL3), c-kit (2B8), CD40 (3/23), and CD86 (GL-1) were purchased from BD Biosciences — Pharmingen. Unlabeled and PE-conjugated anti-mouse FcεRIα (MAR-1) and biotinylated anti–Gr-1 (RB6-8C5), anti-F4/80 (BM8), anti-CD3 (145-2C11), MHC class II (M5/114.15.2), and CD80 (16-10A1) were from eBioscience. The HRP-conjugated goat anti-rat IgG was obtained from Santa Cruz Biotechnology Inc. The basophil-depleting, anti-CD200R3 mAb (Ba103) and the anti–mMCP-8 mAb (TUG8) were established as reported previously (26, 27, 44).
Semiquantitative RT-PCR analysis. Total RNA was prepared from pieces of skin taken from tick-feeding sites and subjected to first-strand cDNA synthesis with reverse transcription using oligo(dT)primers. Semiquantitative PCR was performed with 5-fold serially diluted cDNA templates using the following primers: for Mcpt8, forward, 5′-CCGGAATTCATGTTCCTGCTCCTGGTCC-3′ and reverse 5′-CGCGGATCCCTAGGGTTGTTGCAGGAGTTTCATTG-3′; for Mcpt4, forward 5′-GGGCTGGAGCTGAGGAGATT-3′ and reverse 5′-CTTCTGCTGTGTGGATTCTGTC-3′; and for Hprt1, forward, 5′-GCTGGTGAAAAGGACCTCT-3′ and reverse 5′-CACAGGACTAGAACACCTGC-3′.
Flow cytometric and histological analyses. Pieces of skin from the tick-feeding sites were treated with collagenase (130 U/ml, Wako Pure Chemical) in RPMI complete medium at 37°C for 2 hours to obtain single-cell suspensions. Cells prepared from skin, bone marrow, the peritoneal cavity, and peripheral blood were depleted of rbcs by lysis with hypotonic buffer and preincubated with anti-CD16/32 (2.4G2) mAb (BD Biosciences — Pharmingen) and normal rat serum on ice for 10 minutes to prevent the nonspecific binding of other Abs. Cells were stained with the indicated combinations of Abs and analyzed by FACSCalibur (BD Biosciences): basophils (IgE+c-kit– or FcεRIα+CD49b+), mast cells (IgE+c-kit+ or FcεRIα+c-kit+), eosinophils (Gr-1intsiglec-F+), neutrophils (Gr-1hi), T cells (CD3+), B cells (CD19+), NK cells (NK1.1+CD49b+), monocytes/macrophages (Gr-1intSiglec-F–), macrophages (CD11b+F4/80+), plasmacytoid DCs (pDCs, CD11cintB220+), and conventional DCs (cDCs, CD11chiB220–). For immunohistochemical examination, paraffin-embedded skin specimens were prepared and pretreated as described (44), and tissue sections were incubated with anti-mMCP-8 (1 μg/ml) or an isotype-matched control antibody at 4°C overnight, followed by HRP-conjugated goat anti-rat IgG (diluted 1:500). The sections were subsequently incubated in a DAB solution (Dako) and counterstained with H&E. Mast cells in the skin tissue sections were identified by toluidine blue staining (pH 2.5).
Basophil depletion. For the antibody-mediated depletion of basophils, mice were treated with either Ba103 or MAR-1. One intravenous injection of 50 μg Ba103 or control rat IgG was given 1 day before the tick infestation. A total of 30 μg MAR-1 or control hamster IgG was administered intraperitoneally twice a day (5 μg each time) for 3 consecutive days, starting 4 days before the tick infestation. For the DT-mediated depletion, Mcpt8DTR mice were given an intravenous injection of DT (750 ng/20 g body weight; Sigma-Aldrich).
Adoptive transfer of cells. Mouse bone marrow cells were cultured with 3.5 ng/ml rIL-3 and 15 ng/ml rSCF for approximately 4–6 weeks to obtain BMMCs. A total of 106 BMMCs was injected in 10 separate intradermal injections to form a circle (16 mm in diameter) on the right flank of KitW-sh/W-sh mice. Four weeks later, the mice were infested with tick larvae, first on the left flank and then, 2 weeks later, by a second infestation in which the larvae were placed within the BMMC-injected site. For the adoptive transfer of basophils, spleen cells were isolated from mice that were uninfested or infested with ticks 2 weeks previously, and the basophil-enriched CD49b+ fraction was prepared by using the BD IMag Cell Separation System (BD Biosciences — Pharmingen). Mice were infested with ticks 2 hours after the adoptive transfer of the CD49b+ fraction (1.5 × 106 cells).
Passive cutaneous anaphylaxis. Mice were passively sensitized with an intradermal injection of TNP-specific IgE or control PBS into the ear and challenged 24 hours later with an intravenous injection of TNP-OVA plus 0.5% Evans blue dye as described. The absorbance of Evans blue in the ear extract was measured with a spectrophotometer at 620 nm.
Statistics. Statistical significance (P < 0.05) was determined by 2-tailed Student’s t test or ANOVA followed by Ryan’s test.
We thank K. Fujisaki for providing ticks; S.J. Galli, S. Nakae, and K. Sudo for providing KitW-sh/W-sh C57BL/6 mice; J. Miyazaki for providing CAG-cre transgenic mice; M. Matsuda for helping with the generation of Mcpt8DTR mice; and M. Egawa and H. Ogawa for breeding mice. This work was supported by research grants from JST, CREST, the Japanese Ministry of Education, Culture, Sports, Science and Technology, Takeda Science Foundation, the Mitsubishi Foundation, the Naito Foundation, and the Uehara Memorial Foundation.
Address correspondence to: Hajime Karasuyama, Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81.3.5803.5162; Fax: 81.3.3814.7172; E-mail: karasuyama.mbch@tmd.ac.jp.
Conflict of interest: The authors have declared that no conflict of interest exists.
Reference information: J Clin Invest. 2010;120(8):2867–2875. doi:10.1172/JCI42680.
See the related article at Mice that “conditionally” lack basophils, AT LAST.